Advertisements

Contact Jackie Buckle to advertise here:

 

Tony D'Agostino

 

Drug & Alcohol Training Programme

 

Due to the recent Covid-19 pandemic all drug and alcohol courses are being delivered online to professionals via Zoom, Microsoft Teams and Webex.

 

Learn more....

 

...........................

 

ESH

 

Sustained Recovery Success – Competitive Realistic Prices

 

ESH Community is an independent not-for-profit organisation, so we're able to offer our continued competitive prices for 2020 without compromising the quality of service and the high standards that have achieved our on-going track record of success. We’re now also accepting residents for minimum 28 days for private and local authority placements. Give us a call to see how we can help.

...........................

 

Comments / sponsorship

If you have any comments about DS Daily or to find out about sponsorship please contact the Editor: Jackie Buckle

 

 

Disclaimer

DS Daily, twitter and Facebook are intended purely as current awareness resources. DS Daily does not endorse nor guarantee the accuracy of the information provided by external sources/links, and accepts no responsibility or liability for any consequences arising from the use of such data. See our editorial policy here

subscribe

 

 

We are pleased to present DS Daily in association with

 

DDN

 

Follow DDN on Facebook


Thank you to our gold sponsors:

 

 

Bristol Drugs Project

 

ESH

 

 

Forward Trust logo

 

 
Thank you to our silver sponsors:

 

APCDLOlogo

 

 

 

PHElogo

Alcohol and drug misuse prevention and treatment guidance


Information and other resources to support commissioners, service providers and others providing alcohol and drug interventions

 

----------------------------

 

Could you sponsor DS Daily? Your logo will appear here with a link to your website. Please Email
Harry Shapiro


Follow DrugScope on Twitter

 

Bookmark and Share

 

...............................


 

 

 

Thank you to our Premium sponsors:

 

CGL logo

 

 

Turning Point

 

 

Phoenix Futures logo

 

 

We are with you logo

 

Could you sponsor DS Daily? Please Email Harry Shapiro to discuss

 

Reports: May

 

Novel benzodiazepines: prevalence and harms in the UK

This report examines the evidence of prevalence and harms in the UK of several novel benzodiazepines and provides advice to the government | ACMD, UK

Safety of low dose cannabidiol (PDF)

Cannabidiol (CBD), a cannabinoid derived from the Cannabis plant, is being supplied as a medicine in Australia, but often as a component of oils and extracts of cannabis. A purified product has recently been approved for treatment of certain paediatric epilepsies in the US and is under regulatory evaluation in Australia as a registered medicine | Australian Government, Australia

COVID-19 and the drug supply chain: from production and trafficking to use (PDF)

Drug trafficking relies heavily on legal trade to camouflage its activities and on individuals being able to distribute drugs to consumers. The measures implemented by Governments to counter the COVID19 pandemic have thus inevitably affected all aspects of the illegal drug markets, from the production and trafficking of drugs to their consumption | UNODC, Austria

State of the Sector 2019: Drug and Alcohol Family Support (PDF)

Almost one in three adults in Great Britain have been negatively affected by the substance use of someone they know, and one in ten describe themselves as currently affected. Providing support to families has been shown to improve the chances that their loved one will enter, and remain in, treatment. But equally important is the right to support for themselves. Adfam’s State of the Sector Family Support Survey aims to shine a light on current circumstances and practice | Adfam, UK

COVID-19: New EMCDDA study highlights drop in availability of drug services in Europe but increase in innovation

As Europe grapples with the unprecedented public health threat posed by COVID-19, how is the outbreak affecting drug users and service providers? In a new study published today — Impact of COVID-19 on drug services and help-seeking in Europe — the EMCDDA reports signs of a drop in the availability of drug services during the pandemic and in the numbers of those seeking help | EMCDDA, Portugal

Assessing the Evidence on Supervised Drug Consumption Sites

Current levels of opioid-related morbidity and mortality in the United States are staggering. Data for 2017 indicate that there were more than 47,000 opioid-involved overdose deaths (roughly similar to deaths from AIDS at its peak in 1995), and 1 in 8 adults now report having had a family member or close friend die from opioids | RAND, USA

Death of despair (PDF)

More Americans could lose their lives to deaths of despair, deaths due to drug, alcohol, and suicide, if we do not do something immediately. Deaths of despair have been on the rise for the last decade, and in the context of COVID-19, deaths of despair should be seen as the epidemic within the pandemic. The goal of this report is to predict what deaths of despair we might see based on three assumptions during COVID-19: economic recovery, relationship between deaths of despair and unemployment, and geography | Wellbeing Trust, USA

The UK Medicinal Cannabis Report: The Needs of A Nation - Part A: “The Current Landscape”

Free download on registration. This report intends to highlight some of the changes needed to achieve the aspirations behind the rescheduling of cannabis in 2018 | CDPG, UK

CND decision on international control of two fentanyl analogues enters into force - remaining decisions will enter into force in November 2020

The decision adopted by the Commission on Narcotic Drugs (CND) during its 63nd Session from 2 to 6 March 2020 to add Crotonylfentanyl and Valerylfentanyl to Schedule I of the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, was communicated by the Secretary-General on 7th of May 2020 to all States Members of the United Nations... | UNODC, Austria

Adulterants, Contaminants and Co-occurring Substances in Drugs on the Illegal Market in Canada (CCENDU Bulletin)

Provides a snapshot of the contents of drugs on the illegal market in Canada using 2018–2019 data from drug seizures, drug checking services and a drug monitoring study. This bulletin is accompanied by a technical report featuring detailed research methods and data | CCSA, Canada

The cost of opioid use to Australia: $15.7 billion and 2203 deaths

The ‘extra-medical’ use of opioids is costing Australia around $15.7 billion and causing more than 2200 deaths a year. ‘Extra-medical’ opioid use includes the illegal use of heroin and the misuse of pharmaceutical opioids (use ‘not as prescribed’) | NDARC, Australia

Inequalities in victimisation: alcohol, violence, and anti-social behaviour

New findings show that alcohol-related violence affects the poorest in society to the greatest degree, with the most deprived groups experiencing as much as 14 times as many incidents of alcohol-related domestic violence every year, compared with the least deprived | IAS, UK

Testing for drug-related infectious diseases — a crucial step towards meeting international health goals

Testing for drug-related infectious diseases among people who inject drugs (PWID) is crucial if international health targets are to be met. This is among the conclusions of a new EMCDDA report out today | EMCDDA, Portugal